Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the non-inferiority of BF-200 ALA (Ameluz) in the
treatment of actinic keratosis (AK) with photodynamic therapy (PDT) compared to Metvix.